신경계 질환용 정밀 모니터링 시장 분석 및 예측(-2035년) : 유형, 제품, 서비스, 기술, 구성 요소, 용도, 디바이스, 전개, 최종 사용자, 솔루션

The global Advanced Monitoring for Neurological Disorders Market is projected to grow from $4.5 billion in 2025 to $8.2 billion by 2035, at a compound annual growth rate (CAGR) of 6.1%. Growth is driven by increasing prevalence of neurological disorders, advancements in monitoring technology, and rising healthcare expenditure. Enhanced diagnostic capabilities and integration of AI in monitoring systems further propel market expansion. The Advanced Monitoring for Neurological Disorders Market is characterized by a moderately consolidated structure, with the top segments being neuroimaging devices and wearable monitoring devices, holding approximately 45% and 30% of the market share, respectively. Key applications include epilepsy monitoring, sleep disorder diagnosis, and neurodegenerative disease management. The market sees a significant volume of installations, particularly in hospitals and specialized neurological centers, with an increasing trend towards home-based monitoring solutions.

The competitive landscape features a mix of global and regional players, with global companies often leading in technological innovation and product development. The market is marked by a high degree of innovation, particularly in the integration of AI and machine learning for predictive analytics. Recent trends indicate a rise in mergers and acquisitions, as well as strategic partnerships, aimed at expanding product portfolios and geographic reach. Companies are increasingly focusing on collaborations with research institutions to enhance their R&D capabilities and accelerate the development of advanced monitoring technologies.

The 'Type' segment in the advanced monitoring for neurological disorders market is primarily driven by the increasing prevalence of chronic neurological conditions. EEG devices dominate this segment due to their critical role in diagnosing and monitoring epilepsy and sleep disorders. The demand is further propelled by advancements in wearable EEG technology, which offer continuous monitoring capabilities. Emerging subsegments like MEG are gaining traction, supported by their superior spatial resolution, which is crucial for precise brain mapping.

In the 'Technology' segment, non-invasive monitoring technologies lead the market, driven by patient preference for less intrusive diagnostic methods. The integration of AI and machine learning in these technologies enhances data analysis and predictive capabilities, making them indispensable in clinical settings. The development of portable and wireless monitoring devices is a notable trend, catering to the growing need for home-based patient care and remote monitoring solutions.

The 'Application' segment sees significant demand from the epilepsy monitoring subsegment, as it is essential for both diagnosis and management of the condition. Parkinsons disease monitoring is also a key area, with innovations in wearable sensors facilitating real-time tracking of motor symptoms. The rising incidence of Alzheimers disease is spurring growth in cognitive assessment tools, which are increasingly being used in both clinical trials and routine care.

Within the 'End User' segment, hospitals and clinics remain the primary consumers of advanced neurological monitoring devices, driven by the need for accurate diagnostic tools and patient management systems. However, the home care settings subsegment is expanding rapidly, supported by the shift towards patient-centric care models and the increasing availability of user-friendly monitoring devices. This trend is particularly pronounced in regions with aging populations, where home-based care is becoming more prevalent.

The 'Component' segment is dominated by the hardware subsegment, which includes sensors and monitoring devices, essential for capturing accurate physiological data. However, the software component is witnessing robust growth, driven by the need for sophisticated data analysis and interpretation tools. Cloud-based platforms are becoming increasingly popular, offering scalable solutions for data storage and facilitating seamless integration with electronic health records, thereby enhancing clinical decision-making processes.

Geographical Overview

North America: The market for advanced monitoring in neurological disorders is highly mature, driven by robust healthcare infrastructure and significant R&D investments. The United States leads with strong demand from hospitals and research institutions focusing on neurodegenerative diseases. Canada also contributes with its emphasis on healthcare innovation and technology adoption.

Europe: Europe exhibits moderate to high market maturity, with key industries including medical technology and pharmaceuticals driving demand. Germany, the UK, and France are notable countries, leveraging advanced healthcare systems and strong regulatory frameworks to support market growth.

Asia-Pacific: The market is in a growth phase, propelled by increasing healthcare investments and rising prevalence of neurological disorders. China and Japan are at the forefront, with substantial government support for healthcare advancements and a growing focus on medical research and development.

Latin America: The market is emerging, with Brazil and Mexico as primary contributors. The region's growth is driven by improving healthcare infrastructure and increasing awareness of neurological disorders, although economic constraints pose challenges.

Middle East & Africa: The market is nascent, with South Africa and the UAE leading due to investments in healthcare modernization and technology. However, limited access to advanced medical technologies and economic disparities hinder broader market development.

Key Trends and Drivers

Trend 1 Title: Integration of AI and Machine Learning

The Advanced Monitoring for Neurological Disorders Market is increasingly leveraging AI and machine learning technologies to enhance diagnostic accuracy and predictive capabilities. These technologies facilitate the analysis of complex neurological data, enabling early detection of disorders such as Alzheimer's and Parkinson's. By improving the precision of monitoring systems, AI-driven solutions are reducing the time to diagnosis and enhancing patient outcomes. This trend is driven by ongoing advancements in computational power and the availability of large datasets for training sophisticated algorithms.

Trend 2 Title: Rise of Wearable Neurological Devices

Wearable technology is transforming the landscape of neurological monitoring by providing continuous, real-time data collection in non-clinical settings. Devices such as EEG headbands and smartwatches equipped with neurological sensors are gaining traction due to their convenience and ability to monitor patients remotely. This trend is supported by the growing consumer demand for personalized health solutions and the increasing prevalence of neurological disorders. Wearable devices are becoming integral to patient management, offering insights into disease progression and treatment efficacy.

Trend 3 Title: Regulatory Support and Reimbursement Policies

Governmental and regulatory bodies are increasingly recognizing the importance of advanced neurological monitoring technologies, leading to more favorable regulatory frameworks and reimbursement policies. This support is crucial in facilitating the adoption of innovative monitoring solutions by healthcare providers. Regulatory agencies are working to streamline approval processes and ensure that new technologies meet safety and efficacy standards. Enhanced reimbursement policies are also encouraging healthcare facilities to invest in cutting-edge monitoring systems, thereby expanding market access.

Trend 4 Title: Telehealth and Remote Monitoring Expansion

The expansion of telehealth services is significantly impacting the Advanced Monitoring for Neurological Disorders Market. Remote monitoring solutions are becoming more prevalent, allowing healthcare providers to manage patients with neurological disorders from a distance. This trend is accelerated by the need for continuous patient care and the convenience of reducing in-person visits, especially in the context of the COVID-19 pandemic. Telehealth platforms are integrating advanced monitoring tools, providing comprehensive care solutions that improve patient engagement and adherence.

Trend 5 Title: Advancements in Brain-Computer Interface (BCI) Technologies

Innovations in brain-computer interface (BCI) technologies are opening new avenues for monitoring and treating neurological disorders. BCIs enable direct communication between the brain and external devices, offering potential therapeutic applications for conditions such as epilepsy and stroke. The development of non-invasive BCI systems is particularly noteworthy, as they provide safer and more accessible options for patients. This trend is driven by ongoing research and development efforts aimed at enhancing the functionality and user-friendliness of BCI technologies, positioning them as a promising tool in neurological care.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Device
• 2.9 Key Market Highlights by Deployment
• 2.10 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Electroencephalography (EEG)
  • 4.1.2 Magnetoencephalography (MEG)
  • 4.1.3 Intracranial Pressure Monitoring
  • 4.1.4 Cerebral Oximetry
  • 4.1.5 Transcranial Doppler
  • 4.1.6 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Wearable Devices
  • 4.2.2 Non-Wearable Devices
  • 4.2.3 Implantable Devices
  • 4.2.4 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Monitoring Services
  • 4.3.2 Consulting Services
  • 4.3.3 Data Management Services
  • 4.3.4 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Wireless Technology
  • 4.4.2 Wired Technology
  • 4.4.3 Cloud-Based Technology
  • 4.4.4 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Sensors
  • 4.5.2 Software
  • 4.5.3 Hardware
  • 4.5.4 Others
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Epilepsy
  • 4.6.2 Parkinson's Disease
  • 4.6.3 Alzheimer's Disease
  • 4.6.4 Multiple Sclerosis
  • 4.6.5 Traumatic Brain Injury
  • 4.6.6 Others
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Hospitals
  • 4.7.2 Ambulatory Surgical Centers
  • 4.7.3 Home Care Settings
  • 4.7.4 Research Institutes
  • 4.7.5 Others
• 4.8 Market Size & Forecast by Device (2020-2035)
  • 4.8.1 Portable Devices
  • 4.8.2 Stationary Devices
  • 4.8.3 Others
• 4.9 Market Size & Forecast by Deployment (2020-2035)
  • 4.9.1 On-Premise
  • 4.9.2 Cloud-Based
  • 4.9.3 Others
• 4.10 Market Size & Forecast by Solutions (2020-2035)
  • 4.10.1 Diagnostic Solutions
  • 4.10.2 Therapeutic Solutions
  • 4.10.3 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 End User
    • 5.2.1.8 Device
    • 5.2.1.9 Deployment
    • 5.2.1.10 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 End User
    • 5.2.2.8 Device
    • 5.2.2.9 Deployment
    • 5.2.2.10 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 End User
    • 5.2.3.8 Device
    • 5.2.3.9 Deployment
    • 5.2.3.10 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 End User
    • 5.3.1.8 Device
    • 5.3.1.9 Deployment
    • 5.3.1.10 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 End User
    • 5.3.2.8 Device
    • 5.3.2.9 Deployment
    • 5.3.2.10 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 End User
    • 5.3.3.8 Device
    • 5.3.3.9 Deployment
    • 5.3.3.10 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 End User
    • 5.4.1.8 Device
    • 5.4.1.9 Deployment
    • 5.4.1.10 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 End User
    • 5.4.2.8 Device
    • 5.4.2.9 Deployment
    • 5.4.2.10 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 End User
    • 5.4.3.8 Device
    • 5.4.3.9 Deployment
    • 5.4.3.10 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 End User
    • 5.4.4.8 Device
    • 5.4.4.9 Deployment
    • 5.4.4.10 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 End User
    • 5.4.5.8 Device
    • 5.4.5.9 Deployment
    • 5.4.5.10 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 End User
    • 5.4.6.8 Device
    • 5.4.6.9 Deployment
    • 5.4.6.10 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 End User
    • 5.4.7.8 Device
    • 5.4.7.9 Deployment
    • 5.4.7.10 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 End User
    • 5.5.1.8 Device
    • 5.5.1.9 Deployment
    • 5.5.1.10 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 End User
    • 5.5.2.8 Device
    • 5.5.2.9 Deployment
    • 5.5.2.10 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 End User
    • 5.5.3.8 Device
    • 5.5.3.9 Deployment
    • 5.5.3.10 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 End User
    • 5.5.4.8 Device
    • 5.5.4.9 Deployment
    • 5.5.4.10 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 End User
    • 5.5.5.8 Device
    • 5.5.5.9 Deployment
    • 5.5.5.10 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 End User
    • 5.5.6.8 Device
    • 5.5.6.9 Deployment
    • 5.5.6.10 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 End User
    • 5.6.1.8 Device
    • 5.6.1.9 Deployment
    • 5.6.1.10 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 End User
    • 5.6.2.8 Device
    • 5.6.2.9 Deployment
    • 5.6.2.10 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 End User
    • 5.6.3.8 Device
    • 5.6.3.9 Deployment
    • 5.6.3.10 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 End User
    • 5.6.4.8 Device
    • 5.6.4.9 Deployment
    • 5.6.4.10 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 End User
    • 5.6.5.8 Device
    • 5.6.5.9 Deployment
    • 5.6.5.10 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Medtronic
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 GE Healthcare
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Philips Healthcare
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Natus Medical Incorporated
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Nihon Kohden Corporation
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Siemens Healthineers
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Compumedics Limited
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Masimo Corporation
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Dragerwerk AG
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Integra LifeSciences
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Cadwell Industries
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 NeuroPace
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Neurosoft
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Rimed
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Advanced Brain Monitoring
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Electrical Geodesics
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 NeuroSky
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Mindray Medical International
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Emotiv
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Neuroelectrics
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us